Sigma Healthcare Limited (S5YA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sigma Healthcare Limited (S5YA) has a cash flow conversion efficiency ratio of 0.047x as of January 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€22.39 Million ≈ $26.18 Million USD) by net assets (€477.77 Million ≈ $558.56 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Sigma Healthcare Limited's balance sheet to measure how much of total assets are equity-financed.
Sigma Healthcare Limited - Cash Flow Conversion Efficiency Trend (2017–2023)
This chart illustrates how Sigma Healthcare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Sigma Healthcare Limited earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Sigma Healthcare Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sigma Healthcare Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kyocera Corporation
F:KYRA
|
0.026x |
|
EXACT Sciences Corporation
NASDAQ:EXAS
|
0.063x |
|
Allegheny Technologies Incorporated
NYSE:ATI
|
0.165x |
|
China Merchants Energy Shipping Co Ltd
SHG:601872
|
0.054x |
|
Jardine Matheson Holdings Limited
F:H4W
|
0.025x |
|
E.SUN Financial Holding Co Ltd
TW:2884
|
0.056x |
|
Bouygues SA
PA:EN
|
0.113x |
|
NN Group NV
AS:NN
|
0.001x |
Annual Cash Flow Conversion Efficiency for Sigma Healthcare Limited (2017–2023)
The table below shows the annual cash flow conversion efficiency of Sigma Healthcare Limited from 2017 to 2023. For the full company profile with market capitalisation and key ratios, see Sigma Healthcare Limited stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-01-31 | €477.77 Million ≈ $558.56 Million |
€142.74 Million ≈ $166.88 Million |
0.299x | +415.53% |
| 2022-01-31 | €488.78 Million ≈ $571.43 Million |
€-46.28 Million ≈ $-54.11 Million |
-0.095x | -285.89% |
| 2021-01-31 | €534.90 Million ≈ $625.36 Million |
€-13.12 Million ≈ $-15.34 Million |
-0.025x | -105.77% |
| 2020-01-31 | €476.74 Million ≈ $557.36 Million |
€202.75 Million ≈ $237.04 Million |
0.425x | +2482.27% |
| 2019-01-31 | €514.28 Million ≈ $601.25 Million |
€8.47 Million ≈ $9.90 Million |
0.016x | -88.08% |
| 2018-01-31 | €515.26 Million ≈ $602.39 Million |
€71.18 Million ≈ $83.22 Million |
0.138x | -48.96% |
| 2017-01-31 | €538.59 Million ≈ $629.66 Million |
€145.77 Million ≈ $170.42 Million |
0.271x | -- |
About Sigma Healthcare Limited
Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies primarily in Australia. It offers support services to a network of franchised retail pharmacies; third and fourth party logistics services to pharmaceutical manufacturers and other supplier partners; and health services. The company operates stores under the Chemi… Read more